Abstracts will be accepted for the following presentation types:
- Oral (15 minute presentation (12 minutes for presentation + 2 minutes for Q&A);
- No Preference.
Prior to submitting an abstract, please make sure that you have the following information available:
- Contact information for all authors;
- Biographies for all presenting authors;
- Abstract text in paragraph format (under 3000 characters). Abstracts may contain one table/graph. Images are accepted
(limit of 4), and will be published in black and white in the program
- Session Topic (Bone, Brain, Breast Tumors, Cardiovascular, Head & Neck, Liver, Pancreas, Prostate, Uterine Fibroids, Other).
Each abstract will be reviewed by members of the Scientific Committee with expertise in the topic. Abstracts may be selected for oral and/or poster presentation. Only one author (usually the primary author) may participate in the oral presentation. Authors may submit abstracts of completed work or work in progress. This excludes any work that has already been presented at the national or international level. The primary author is responsible for obtaining written consent from all authors and appropriate institutions prior to submitting an abstract.
The trade name of a drug/device should not be included in the title of the abstract. If required for clarity, the trade name should only be mentioned once between brackets in the body of the abstract. All direct or indirect industry support should be disclosed by simply stating at the bottom of the abstract, i.e. “Supported by…” Industry support will be defined as any support for conducting the study, analyzing the data, preparation of the abstract/presentation, or supporting traveling expenses. Employees of business corporations may submit abstracts that feature their employers’ products or services if they fully disclose their employment and/or financial involvement. Accepted abstracts may not be sales presentations and can not imply any endorsement of said products or services by FUSF. The individual accepted in the oral sessions or poster sessions must make this clear during his or her session.
Poster information (including size, title banner, content, and organization requirements) will be provided once Authors have been notified of Abstract acceptance. Poster guidelines will be available online at www.fusfoundation.org/symposium. At least one author of accepted poster Abstracts must be present at their posters during an assigned session to allow for dialogue with participants. Poster sessions may run concurrently with other Symposium sessions.
All abstracts will be published in the Symposium program and online atwww.fusfoundation.org/symposium.
Symposium registration will be available in February 2012. All presenting authors of abstracts accepted for presentation will be required to register for the Symposium and pay the appropriate fees in accordance with the published fee schedule.